Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2007

01-05-2007 | Clinical Trial

Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients

Authors: Florian Fitzal, Otto Riedl, Lisa Wutzl, Wolfgang Draxler, Margaretha Rudas, Ursula Pluschnig, Leonore Handl-Zeller, Peter Dubsky, Thomas Bachleitner-Hofmann, Günther Steger, Raimund Jakesz, Michael Gnant

Published in: Breast Cancer Research and Treatment | Issue 1/2007

Login to get access
Metadata
Title
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients
Authors
Florian Fitzal
Otto Riedl
Lisa Wutzl
Wolfgang Draxler
Margaretha Rudas
Ursula Pluschnig
Leonore Handl-Zeller
Peter Dubsky
Thomas Bachleitner-Hofmann
Günther Steger
Raimund Jakesz
Michael Gnant
Publication date
01-05-2007
Published in
Breast Cancer Research and Treatment / Issue 1/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9325-6

Other articles of this Issue 1/2007

Breast Cancer Research and Treatment 1/2007 Go to the issue

Epidemiology

Physician and patient characteristics associated with outpatient breast cancer screening recommendations in the United States: analysis of the National Ambulatory Medical Care Survey Data 1996–2004

Erratum

Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo

EPIDEMIOLOGY

Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging

Review Paper

Male breast cancer: a review of clinical management

Letter to the Editor

CHEK2 1100delC is present in familial breast cancer cases of the Basque Country

PRECLINICAL STUDY

Characterization of molecular and structural determinants of selective estrogen receptor downregulators
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits